Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Exclusive-Head of Pemex's production arm to step down in coming days, sources say - 2Aid sent by ambulance to Ukraine front line
- 3Working out at the airport? Some fliers can already smell the sweat.
- 4A hunger for new experiences Narratives: Motivating Travel and Experience
- 5Trump administration plan to reduce access to some student loans angers nurses, health care groups
- Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- I visited every country by 25. Antarctica showed me how much I still hadn't seen.
- Grasping the Basics of Business Land Regulation
- Study reveals links between global food systems, obesity, and climate change
- Renewables cover over 50% of German electricity consumption in Q1
- Washington resident contracts bird flu, first human case in U.S. since February
- Fascinating Fishing Objections From Around The World
- At least 36 dead in major fire in Hong Kong residential blocks
- Sheinelle Jones will cohost fourth hour of 'Today' with Jenna Bush Hager: Here's what to know about her
